Cassava Sciences, Inc. (SAVA)

NASDAQ

$--

(--)

Regular Market

Cassava Sciences, Inc. (SAVA) Live Price Chart

Last updated: ⁦2026-10-21 15:19:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Cassava Sciences, Inc. (SAVA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Cassava Sciences, Inc. (SAVA) Stock Price Today

Cassava Sciences, Inc. (SAVA) is currently trading at $-- as of --, -- from the previous close of $--

During today's regular trading session, SAVA has traded between $-- and $--, with a trading volume of -- shares. The current price is -- of today's range.

Cassava Sciences, Inc. (SAVA) 7-Day Stock Price Change

Over the past seven days, Cassava Sciences, Inc. (SAVA) moved from $2.20 to $2.38, representing a gain of 8.18% ($0.18).

The stock traded between $1.96 and $2.49 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 867.30 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

What is Cassava Sciences, Inc. (SAVA)?

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Cassava Sciences, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	30
Exchange	NASDAQ
Company Website	https://www.cassavasciences.com

How to Buy Cassava Sciences, Inc. (SAVA) Stock on MEXC

Eligible investors can buy real shares of Cassava Sciences, Inc. (SAVA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for SAVA and Place Your Order

Open the RealStocks trading page and search for SAVA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Cassava Sciences, Inc. (SAVA) stock price today?

Cassava Sciences, Inc. (SAVA) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is SAVA stock going up or down today?

As of --, SAVA is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is SAVA pre-market price?

As of --, SAVA is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is SAVA after-hours price?

As of --, SAVA is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is SAVA stock trading now?

SAVA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does SAVA sit relative to its 52-week high and low?

Over the past 52 weeks, SAVA has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Cassava Sciences, Inc. in?

Cassava Sciences, Inc. (SAVA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Cassava Sciences, Inc.'s market capitalization and where is it listed?

Cassava Sciences, Inc. is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is SAVA valued in terms of P/E ratio and EPS?

SAVA trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Cassava Sciences, Inc. pay a dividend?

Cassava Sciences, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.